Novavax COVID-19 vaccine: Serum Institute to start trial next month in India

- US drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually
- Union health minister Harsh Vardhan on Thursday said that COVID-19 vaccine may be available in India by first half of 2021